Refine by
Neuroendocrine Tumor Equipment & Supplies
16 equipment items found
by:Pars Isotope Co based inTehran, IRAN
The PARS-LUTOTATE theranostic radiopharmaceutical kit is an innovative solution formulated as a single vial for the effective treatment of neuroendocrine tumors. It utilizes the Lu-177 radioisotope, enabling the radiopharmaceutical to selectively target neuroendocrine tumor cells, facilitating their complete destruction. This ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
LUTATHERA is a radiolabeled somatostatin analog indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors in ...
Manufactured by:ITM Isotope Technologies Munich SE based inGarching / Munich, GERMANY
Ready-to-use Radiopharmaceutical for Diagnosis & Staging of Neuroendocrine Tumors (NETs) ...
Manufactured by:Ampersand Biosciences based inLake Clear, NEW YORK (USA)
Chromogranin B (CgB) aka Secretogranin-1, Uniprot # P05060, is an acidic member of the granin family found in a variety of neurons and endocrine cells. CgB is a marker in neuroendocrine tumors with plasma levels potentially being associated with disease ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
NETSPOT, after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. ...
Manufactured by:Ampersand Biosciences based inLake Clear, NEW YORK (USA)
Chromogranin A (CgA), UniProt # P10645, is a 439 amino acid member of the granin family of secretory proteins. Found in vesicles of neuroendocrine cells, CgA is considered a valuable marker for neuroendocrine tumors. CgA is a precursor to a number of biologically active peptides including vasostatin I, parastatin, and ...
Manufactured by:SOFIE based inDulles, VIRGINIA (USA)
NETSPOT, after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric ...
Manufactured by:Isotopia Molecular Imaging based inPetah Tikva, ISRAEL
Lutetium-177 (Lu-177) is being widely used as a promising radionuclide for targeted therapy and is emerging as a game-changing theranostic isotope for the treatment of neuroendocrine tumors, metastatic castration-resistant prostate cancer (mCRPC) along with its development for new carrier molecules that can provide selective targeting for tumor ...
Manufactured by:Radium Incorporated based inWaynesboro, VIRGINIA (USA)
ClearView Vial Shield can be used for Ac-225 PSMA, I-123 and I-131 mIBG therapies, Lutathera (Lu-177) therapies for Neuroendocrine Tumor Treatment, FDA approved PluvictoTM (lutetium Lu 177 vipivotide tetraxetan or 177Lu-PSMA-617) for the treatment of prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer (PSMA-positive ...
Manufactured by:Amadix based inValladolid, SPAIN
Performing a differential diagnosis between Pancreatic cancer and other pathologies such as chronic pancreatitis or neuroendocrine tumors. ...
Manufactured by:Radium Incorporated based inWaynesboro, VIRGINIA (USA)
The ClearView Rolling Shield is a mobile rolling shield available in lead equivalency up to 1’’ Pb.Eq. and is being used in several Theranostics suites and radiotherapies such as Ac-225 PSMA, I-123 and I-131 mIBG therapies, Lutathera (Lu-177) therapies for Neuroendocrine Tumor Treatment, FDA approved PluvictoTM (lutetium Lu 177 vipivotide tetraxetan ...
Manufactured by:Radium Incorporated based inWaynesboro, VIRGINIA (USA)
The ClearView Infusion Pump Shield works for infusion treatments from Ac-225 PSMA, I-123 and I-131 mIBG therapies, Lutathera (Lu-177) therapies for Neuroendocrine Tumor Treatment, FDA approved PluvictoTM (lutetium Lu 177 vipivotide tetraxetan or 177Lu-PSMA-617) for the treatment of prostate-specific membrane antigen–positive metastatic castration-resistant ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
This medicinal product is for diagnostic use only. After radiolabelling with gallium (68Ga) chloride solution, the solution of gallium (68Ga) edotreotide obtained is indicated for positron emission tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NET) for localising ...
Manufactured by:STARmed America based inGoyang-si, SOUTH KOREA
The EUSRA™ Endoscopic RF Electrode is a cutting-edge monopolar 19G radiofrequency device engineered for the precise ablation of complex pancreatic tumors, neuroendocrine growths, and cystic neoplasms under endoscopic ultrasound guidance. As a minimally invasive alternative for patients unsuited for surgery, the electrode provides exact local control over advanced ...
Manufactured by:SOFIE based inDulles, VIRGINIA (USA)
Neuraceq is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Toripalimab is the first domestic anti-tumor PD-1 antibody in China. Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract ...